VIR Vir Biotechnology, Inc.
$8.39 -5.41%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-5.41%
YTD
+39.10%
P/E
—
P/B
1.1
ROE
-6.7%
Div yield
—
Beta
1.87
Market cap
$1.6B
RSI (14)
33
Next earnings
Feb 22, 2027
Same sector · Health Care
Compare VIR with NVO and JNJ →Follow VIR in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$8.77
Close
$8.39
Day high
$8.92
Day low
$8.34
Volume
3.1M
Latest headlines
Vir Biotechnology Shares Drop as Biotech Firm Moves Ahead With Stock Sale
Yahoo Finance · Nov 13
Vir Biotechnology stock tumbles on $150M share offering
Investing.com · Nov 13
Sector Update: Healthcare Stocks Rise Pre-Bell Friday
Yahoo Finance · Nov 13
Vir Biotechnology Announces Pricing of Public Offering of Common Stock
Yahoo Finance · Nov 13
Vir Biotechnology Announces Proposed Public Offering
Yahoo Finance · Nov 12
Vir Biotechnology Hepatitis Delta Treatment Meets Phase III Goals, With 79% Virus-Free at Week 48
Yahoo Finance · Nov 10
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Nov 16, 2026 View → 8-K Nov 9, 2026 View → 10-Q Nov 4, 2026 View → 8-K Nov 4, 2026 View → 8-K Oct 28, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell VIR. Try it in the Lab to size a position and see the risk.